Immunogenic tumor cell death for optimal anticancer therapy: The calreticulin exposure pathway

Clinical Cancer Research

Volumn 16, Issue 12, 2010, Pages 3100-3104

  Zitvogel, Laurence ^a,b,c   Kepp, Oliver ^b,c,d   Senovilla, Laura ^b,c,d   Menger, Laurie ^b,c,d   Chaput, Nathalie ^a,b,c   Kroemer, Guido ^b,c,d  

^a University Paris XI   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d Institut Gustave Roussy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CALRETICULIN; CASPASE 8; CELL PROTEIN; DOXORUBICIN; MITOXANTRONE; OXALIPLATIN; PROTEIN BAK; PROTEIN BAP31; PROTEIN BAX; SALUBRINAL; TAUTOMYCIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER THERAPY; CD8+ T LYMPHOCYTE; DRUG ACTIVITY; DRUG SENSITIVITY; ENDOPLASMIC RETICULUM STRESS; EXOCYTOSIS; GOLGI COMPLEX; HUMAN; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW;

ANIMALS; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALRETICULIN; CELL DEATH; CELL LINE, TUMOR; DENDRITIC CELLS; ENDOPLASMIC RETICULUM; HUMANS; NEOPLASM TRANSPLANTATION; NEOPLASMS; ORGANOPLATINUM COMPOUNDS;

EID: 77953701142     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-2891     Document Type: Review

References (42)

1. Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of cancer chemotherapy. Nat Rev Immunol 2008;8:59-73.
2. Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010;29: 1093-102.
3. Denkert C, Loibl S, Noske A, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010;28:105-13.
4. Zitvogel L, Apetoh L, Ghiringhelli F, Andre F, Tesniere A, Kroemer G. The anticancer immune response: indispensable for therapeutic success? J Clin Invest 2008;118:1991-2001.
5. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009;9:353-63.
6. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 2010;140:798-804.
7. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
8. Casares N, Pequignot MO, Tesniere A, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005;202:1691-701.
9. Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007;13:54-61. (Pubitemid 46067386)
10. Obeid M, Tesniere A, Panaretakis T, et al. Ecto-calreticulin in immunogenic chemotherapy. Immunol Rev 2007;220:22-34.
11. Apetoh L, Ghiringhelli F, Tesniere A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007;13:1050-9.
12. Ghiringhelli F, Apetoh L, Tesniere A, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors. Nat Med 2009;15:1170-8.
13. Cao C, Han Y, Ren Y, Wang Y. Mitoxantrone-mediated apoptotic B16-1 cells induce specific anti-tumor immune response. Cell Mol Immunol 2009;6:469-75.
14. Tongu M, Harashima N, Yamada T, Harada T, Harada M. Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma. Cancer Immunol Immunother 2010;59:769-77.
15. Obeid M, Panaretakis T, Joza N, et al. Calreticulin exposure is required for the immunogenicity of ?-irradiation and UVC light-induced apoptosis. Cell Death Differ 2007;14:1848-50.
16. Perez CA, Fu A, Onishko H, Hallahan DE, Geng L. Radiation induces an antitumour immune response to mouse melanoma. Int J Radiat Biol 2009;85:1126-36.
17. Panaretakis T, Joza N, Modjtahedi N, et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 2008;15:1499-509.
18. Panaretakis T, Kepp O, Brockmeier U, et al. Mechanisms of preapoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009;28:578-90.
19. Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005;123:321-34.
20. Franz S, Herrmann K, Furnrohr BG, et al. After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ 2007;14:733-42.
21. De Boo S, Kopecka J, Brusa D, et al. iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells. Mol Cancer 2009;8:108.
22. Kepp O, Galluzzi L, Giordanetto F, et al. Disruption of the PP1/GADD34 complex induces calreticulin exposure. Cell Cycle 2009;8: 3971-7.
23. Scheuner D, Song B, McEwen E, et al. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 2001;7:1165-76.
24. Yamasaki S, Anderson P. Reprogramming mRNA translation during stress. Curr Opin Cell Biol 2008;20:222-6.
25. Talloczy Z, Jiang W, Virgin HW IV, et al. Regulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway. Proc Natl Acad Sci U S A 2002;99:190-5.
26. Tufi R, Panaretakis T, Bianchi K, et al. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin. Cell Death Differ 2008;15:274-82.
27. Villamil Giraldo AM, Lopez Medus M, Gonzalez Lebrero M, et al. The structure of calreticulin C-terminal domain is modulated by physiological variations of calcium concentration. J Biol Chem 2010;285: 4544-53.
28. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 2003;160:1115-27.
29. Rong YP, Aromolaran AS, Bultynck G, et al. Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol Cell 2008;31:255-65.
30. Hetz C, Bernasconi P, Fisher J, et al. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1α. Science 2006;312:572-6.
31. Berwin B, Hart JP, Rice S, et al. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J 2003;22:6127-36.
32. Madeo F, Durchschlag M, Kepp O, et al. Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals. Cell Cycle 2009;8:639-42.
33. Kepp O, Senovilla L, Galluzzi L, et al. Viral subversion of immunogenic cell death. Cell Cycle 2009;8:860-9.
34. Regan JA, Laimins LA. Bap31 is a novel target of the human papillomavirus E5 protein. J Virol 2008;82:10042-51.
35. Pavio N, Romano PR, Graczyk TM, Feinstone SM, Taylor DR. Protein synthesis and endoplasmic reticulum stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation factor 2α kinase PERK. J Virol 2003;77:3578-85.
36. Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R. Hepatitis C virus core protein inhibits tumor necrosis factor α-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J Virol 2006;80:4372-9.
37. Chignard N, Shang S, Wang H, et al. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology 2006;130:2010-22.
38. Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol 2006; 90:1-50.
39. Cathro HP, Smolkin ME, Theodorescu D, Jo VY, Ferrone S, Frierson HF, Jr. Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas. Cancer Immunol Immunother 2010;59:465-72.
40. Leys CM, Nomura S, LaFleur BJ, et al. Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer. Surgery 2007;141:41-50.
41. Gold LI, Eggleton P, Sweetwyne MT, et al. Calreticulin: nonendoplasmic reticulum functions in physiology and disease. FASEB J 2010;24:665-83.
42. Tesniere A, Schlemmer F, Boige V, et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 2010;29:482-91.